General Information of the Compound
| Compound ID |
CP0385350
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[4-methyl-3-[1-(pyridine-4-carbonyl)piperidin-4-yl]oxyphenyl]-3-(trifluoromethyl)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H24F3N3O3
|
||||||||||||||||||
| Molecular Weight |
483.49
|
||||||||||||||||||
| Canonical SMILES |
Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1OC1CCN(CC1)C(=O)c1ccncc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H24F3N3O3/c1-17-5-6-21(31-24(33)19-3-2-4-20(15-19)26(27,28)29)16-23(17)35-22-9-13-32(14-10-22)25(34)18-7-11-30-12-8-18/h2-8,11-12,15-16,22H,9-10,13-14H2,1H3,(H,31,33)
Show/Hide
|
||||||||||||||||||
| InChIKey |
XFHUWXYRCAAZHK-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00888, Mast/stem cell growth factor receptor Kit
Cell-based Assay
Protein ID: PT00844, Platelet-derived growth factor receptor beta
Cell Viability or Cytotoxicity Assay
| Cell Line ID | Cell Line Name | Cell Line Organism | |
| CL000091 | MV4-11 | Homo sapiens (Human) | 1 |
| 1 |
GI50 > 10000 nM
|
TI
LI
LO
TS
|
|
|---|---|---|---|